Repare Therapeutics Inc. / Insider Transactions

    Source Name Title Transaction Date Shares Price Value

    Configure table

    Control which columns are visible


    Export the current table view as a CSV file, which you can open in programs like Excel or Google Sheets.

    SEC Forte Steve EVP, CHIEF FINANCIAL OFFICER -6.9K $1.14 -$7.85K
    SEC Koehler Maria EVP, CHIEF MEDICAL OFFICER -3.6K $1.14 -$4.10K
    SEC Segal Lloyd Mitchell PRESIDENT AND CEO -21K $1.14 -$24.14K
    SEC Zinda Michael EVP, CHIEF SCIENTIFIC OFFICER -5.6K $1.14 -$6.40K
    SEC Forte Steve EVP, CHIEF FINANCIAL OFFICER -1.6K $4.62 -$7.46K
    SEC Koehler Maria EVP, CHIEF MEDICAL OFFICER -800 $4.65 -$3.72K
    SEC Segal Lloyd Mitchell PRESIDENT AND CEO -5.1K $4.62 -$23.75K
    SEC Zinda Michael EVP, CHIEF SCIENTIFIC OFFICER -860 $4.65 -$4.00K
    SEC Forte Steve EVP, CHIEF FINANCIAL OFFICER -2.5K $4.67 -$11.56K
    SEC Koehler Maria EVP, CHIEF MEDICAL OFFICER -1.5K $4.67 -$7.01K
    SEC Segal Lloyd Mitchell PRESIDENT AND CEO -8K $4.69 -$37.29K
    SEC Zinda Michael EVP, CHIEF SCIENTIFIC OFFICER -1.4K $4.67 -$6.30K
    SEC Zinda Michael EVP, Chief Scientific Officer -3.5K $12.03 -$42.53K
    SEC Zinda Michael EVP, Chief Scientific Officer -1.2K $12.04 -$14.45K
    SEC Koehler Maria EVP, Chief Medical Officer +49K $2.06 +$99.92K
    SEC Jerel Davis N/A -250K $16.00 -$4.00M
    SEC LAMPERT MARK N N/A +149K $12.73 +$1.90M
    SEC Jerel Davis N/A -1.4M $5.22 -$7.47M
    SEC LAMPERT MARK N N/A +1.8M $11.90 +$21.86M
    SEC Versant Vantage I GP-GP, LLC N/A -1.5M $5.24 -$7.60M
    SEC Versant Ventures V (Canada), L.P. N/A -1.5M $5.24 -$7.60M
    SEC LAMPERT MARK N N/A +420K $8.50 +$3.57M
    SEC Zinda Michael EVP, Chief Science Officer -533 $11.30 -$6.02K
    SEC LAMPERT MARK N N/A +998K $14.10 +$14.07M
    SEC Koehler Maria EVP, Chief Medical Officer +49K $2.06 +$99.93K
    SEC Zinda Michael EVP, Chief Science Officer +46K $2.00 +$92.08K
    SEC Civik Thomas N/A +7.5K $28.08 +$210.60K
    SEC Zinda Michael EVP, Chief Science Officer -20K $27.33 -$546.60K
    SEC Bonita David P N/A -8.1K $33.99 -$274.78K
    SEC ORBIMED CAPITAL LLC N/A -8.1K $33.99 -$274.78K
    SEC Bonita David P N/A -38K $34.08 -$1.29M
    SEC ORBIMED CAPITAL LLC N/A -38K $34.08 -$1.29M
    SEC Bonita David P N/A -18K $34.07 -$615.75K
    SEC ORBIMED CAPITAL LLC N/A -18K $34.07 -$615.75K
    SEC Bonita David P N/A -18K $34.17 -$622.41K
    SEC ORBIMED CAPITAL LLC N/A -18K $34.17 -$622.41K
    SEC Bonita David P N/A -41K $34.10 -$1.39M
    SEC ORBIMED CAPITAL LLC N/A -20K $34.10 -$693.18K
    SEC Zinda Michael EVP, Chief Science Officer -15K $33.99 -$509.85K
    SEC Foley Todd N/A -27K $33.55 -$917.63K
    SEC GADICKE ANSBERT N/A -62K $33.55 -$2.08M
    SEC Foley Todd N/A -8.5K $34.06 -$288.15K
    SEC GADICKE ANSBERT N/A -19K $34.06 -$653.95K
    SEC Segal Lloyd Mitchell President and CEO -1.5K $35.61 -$54.91K
    SEC Foley Todd N/A -13K $33.51 -$423.57K
    SEC GADICKE ANSBERT N/A -29K $33.51 -$961.33K
    SEC Foley Todd N/A -19K $34.36 -$648.00K
    SEC GADICKE ANSBERT N/A -43K $34.36 -$1.47M
    SEC Foley Todd N/A -18K $33.77 -$617.79K
    SEC GADICKE ANSBERT N/A -42K $33.77 -$1.40M
    SEC Foley Todd N/A -2.7K $33.25 -$91.20K
    SEC GADICKE ANSBERT N/A -6.2K $33.25 -$207.05K
    SEC Foley Todd N/A -27K $34.05 -$921.63K
    SEC GADICKE ANSBERT N/A -61K $34.05 -$2.09M
    SEC Segal Lloyd Mitchell President and CEO -1.6K $35.00 -$55.16K
    SEC Foley Todd N/A -26K $32.01 -$820.16K
    SEC GADICKE ANSBERT N/A -58K $32.01 -$1.86M
    SEC Segal Lloyd Mitchell President and CEO -36K $27.90 -$1.00M
    SEC Foley Todd N/A -17K $32.47 -$545.04K
    SEC GADICKE ANSBERT N/A -38K $32.47 -$1.24M
    SEC Foley Todd N/A -17K $32.82 -$557.58K
    SEC GADICKE ANSBERT N/A -39K $32.82 -$1.27M
    SEC Foley Todd N/A -143K $34.75 -$4.97M
    SEC GADICKE ANSBERT N/A -325K $34.75 -$11.29M
    SEC Foley Todd N/A -43K $16.71 -$710.19K
    SEC GADICKE ANSBERT N/A -69K $23.45 -$1.61M
    SEC Segal Lloyd Mitchell President and CEO -3.8K $35.03 -$132.06K
    SEC Segal Lloyd Mitchell President and CEO -5.6K $35.04 -$196.22K
    SEC Zinda Michael EVP, Chief Science Officer -15K $32.71 -$490.65K
    SEC Segal Lloyd Mitchell President and CEO -5.5K $35.01 -$192.98K
    SEC Foley Todd N/A -401K $28.18 -$11.29M
    SEC GADICKE ANSBERT N/A -671K $28.18 -$18.90M
    SEC Zinda Michael EVP, Chief Science Officer -35K $33.87 -$1.18M
    SEC Bonita David P N/A +3.4M $20.00 +$67.51M
    SEC EVNIN LUKE N/A +3M $20.00 +$60.08M
    SEC Foley Todd N/A +3M $20.00 +$60.08M
    SEC Forte Steve EVP, Chief Financial Officer +5K $20.00 +$100.00K
    SEC GADICKE ANSBERT N/A +5.4M $20.00 +$107.84M
    SEC Jerel Davis N/A +6.5M $20.00 +$129.91M
    SEC Morrison Briggs N/A +4.8K $20.00 +$96.00K
    SEC ORBIMED CAPITAL LLC N/A +3.4M $20.00 +$67.51M
    SEC RHOADS ANN D N/A +4K $20.00 +$80.00K
    SEC SCHAFER CAROL N/A +8K $20.00 +$160.00K
    SEC Segal Lloyd Mitchell President and CEO +5K $20.00 +$100.00K
    SEC Versant Vantage I GP-GP, LLC N/A +6.5M $20.00 +$129.91M
    SEC Versant Ventures V (Canada), L.P. N/A +6.5M $20.00 +$129.91M

    Notifications